The market performance of Brainstorm Cell Therapeutics, Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.46 on 03/31/23, with the lowest value for the same timeframe being $0.13, recorded on 10/31/23.
52-week price history of BCLI Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -81.07% away from its 52-week high, while its distance from the 52-week low is 388.81%. The stock’s price range for this period has remained between $0.13 and $3.46. The Healthcare sector company’s shares managed to surpass a trading volume of around 4.64 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.4 million over the last three months.
Financial Performance and Market Capitalization
Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly rise of 239.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.08M and boasts a workforce of 43 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2949, with a change in price of +0.5009. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 2,028,145 in trading volume during the last 100 days, posting a change of +335.95%.
BCLI Stock Stochastic Average
As of today, the raw stochastic average of Brainstorm Cell Therapeutics, Inc. over the past 50 days is 73.08%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 73.08%. Additionally, the Stochastic %K and %D values for the company were 81.18% and 81.44%, respectively, over the past 20 days.
BCLI Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 139.93%. However, over the past six months, we’ve seen a stronger performance of -30.32%. The price of BCLI fallen by 87.68% over the last 30 days. And in the last five days, it has surged by 99.45%.
